Teich, K., Krzykalla, J., Kapp-Schwoerer, S., Gaidzik, V. I., Schlenk, R. F., Paschka, P., Weber, D., Fiedler, W., Kühn, M. W., Schroeder, T., Mayer, K., Lübbert, M., Ramachandran, D., Benner, A., Ganser, A., Döhner, H., Heuser, M., Döhner, K. and Thol, F. (2021) “Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with <i>nucleophosmin1</i&gt;-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin”, Haematologica. Pavia, Italy, 106(11), pp. 2986-2989. doi: 10.3324/haematol.2021.278894.